Canopy Growth Corporation
NMS: CGCLive Quote
📈 ZcoreAI Score
Our AI model analyzes Canopy Growth Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get CGC Z-Score →About Canopy Growth Corporation
Healthcare
Drug Manufacturers - Specialty & Generic
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
📊 Fundamental Analysis
Canopy Growth Corporation demonstrates a profit margin of -117.3%, which is below the sector average, suggesting competitive pressure.
The company recently reported -0.3% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -48.5%, which indicates that capital utilization is currently under pressure.
At a current price of $1.05, CGC currently trades near the bottom of its 52-week range (13%), indicating potential value or weakness (Range: $0.84 - $2.38).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$471.53M
Trailing P/E
--
Forward P/E
-14.37
Beta (5Y)
2.32
52W High
$2.38
52W Low
$0.84
Avg Volume
9.82M
Day High
Day Low